US 7115637
Inhibitors of p38
granted A61PA61P1/00A61P1/02
Quick answer
US patent 7115637 (Inhibitors of p38) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/16